Summary
This prediction ended on 26.02.24 with a price of €28.69. Massive losses of -51.27% were the result for the BUY prediction by Biggybaer. Biggybaer has a follow-up prediction for Bayer AG where he still thinks Bayer AG is a Buy. Dividends of €2.55 are taken into consideration when calculating the performance. This prediction was marked as speculative and is excluded from Biggybaer's performance statistics.Bayer is a multinational pharmaceutical and life sciences company headquartered in Germany. The company was founded in 1863 and has since grown to become a global leader in the fields of pharmaceuticals, agriculture, and consumer health. Bayer is listed on the Frankfurt Stock Exchange and also trades over-the-counter in the United States under the ticker symbol BAYZF. The company's products include prescription drugs, over-the-counter medicines, and agrochemicals, and it operates in more than 90 countries around the world.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Bayer AG | 2.085% | 2.085% | 94.963% | -33.660% |
| iShares Core DAX® | 4.244% | 2.864% | 14.030% | 49.549% |
| iShares Nasdaq 100 | 4.890% | 2.814% | 32.707% | 85.974% |
| iShares Nikkei 225® | 9.397% | 7.826% | 48.296% | 63.319% |
| iShares S&P 500 | 3.528% | 1.950% | 25.247% | 62.380% |
Comments by Biggybaer for this prediction
In the thread Bayer AG diskutieren
Buy mit Kursziel 65,0
In the thread Trading Bayer AG
Die von Biggybaer gewählte maximale Laufzeit wurde überschritten